| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,151,769 | 824,509 | 621,998 | 449,741 | | Cost of Revenue | 547,391 | 414,074 | 380,857 | 476,847 | | | Gross Profit | 604,378 | 410,435 | 241,141 | (27,106) | | | Operating Expenses | | Research Development | (10,423) | 10,423 |
-
|
-
| | Selling General and Administrative | 23,804 | 18,101 | 18,792 | 25,114 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 82,266 | 78,715 | 78,221 | 78,963 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 508,731 | 303,196 | 144,128 | (131,183) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,568 | 3,896 | 7,326 | (64,394) | | Earnings Before Interest And Taxes | 510,299 | 307,092 | 151,454 | (195,577) | | Interest Expense | 28,413 | 19,650 | 24,183 | 14,622 | | Income Before Tax | 481,886 | 287,442 | 127,271 | (210,199) | | Income Tax Expense | 167,661 | 111,413 | 48,025 | (85,291) | | Minority Interest | (1,774) | (1,061) | (554) | 249 | | | | Net Income From Continuing Ops | 312,451 | 174,968 | 78,692 | (124,659) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 312,451 | 174,968 | 78,692 | (124,659) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $312,451 | $174,968 | $78,692 | ($124,659) |
|
0.51% Nasdaq 
Income Statement
